🇺🇸 FDA
Patent

US 11192936

Factor VIII chimeric proteins and uses thereof

granted A61KA61K38/00A61P

Quick answer

US patent 11192936 (Factor VIII chimeric proteins and uses thereof) held by BIOVERATIV THERAPEUTICS INC. expires Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BIOVERATIV THERAPEUTICS INC.
Grant date
Tue Dec 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
58
CPC classes
A61K, A61K38/00, A61P, A61P19/00, A61P7/04